Skip to main content
Premium Trial:

Request an Annual Quote

Martin Wells, Gregory Schiffman, Exiqon, National Institutes of Health


People in the News

Nonlinear Dynamics has appointed Martin Wells as international sales manager. Martin joins the UK-based bioinformatics firm from Helena BioSciences where he worked for 13 years, holding a variety of senior sales and marketing positions in their Life Sciences and Clinical In Vitro Diagnostics division.

Nonlinear said that the appointment of Martin was part of their effort to build the customer base for its electrophoresis gel, mass spectrometry, and microarray data analysis tools into the European market.

Gregory Schiffman has been added to Nanomix's board of directors, the nanotechnology company said this week. He has also been appointed chairperson of Nanomix's Audit Committee.

Schiffman is currently the executive vice president and chief financial officer of Affymetrix. He joined Affymetrix in 2001 from Applied Biosystems where he held the position of vice president, controller. He also has experience in finance, manufacturing and distribution management from his prior tenure with Hewlett Packard and IBM.

Schiffman holds a BSc from DePaul University and an MBA from Northwestern University.


New Product Watch

Exiqon this week announced the launch of its miRCURY Arrays for profiling of miRNAs in human, mouse and rat.

The Copenhagen, Denmark-based company also launched its miRCURY Array Labeling kit for direct labeling of miRNAs from total RNA. Products are available worldwide directly from Exiqon.

Exiqon said that the miRCURY Array product enables miRNA expression profiling in samples of down to 1µg of labeled total RNA and uses the firm's high-affinity nucleotide analogue locked nucleic acid technology to enhance hybridization.

The National Institutes of Health announced last week that it is seeking licensees for two array-related technologies.

The first, Methods for Manipulating Nucleic Acids, provides methods for amplifying nucleic acid templates from small samples. The nucleic acid templates amplified by the disclosed methods can be used in combination with any method and can be labeled with any labeling method, the NIH said.

The second available technology, Amine Modified Random Primers for Microarray Detection, provides a method for labeling nucleic acid molecules for use in hybridization reactions, and kits employing these methods. According to the NIH, the fluorescence-labeled cDNA probes for DNA microarray studies also use less input RNA.

Those interested should contact NIH's Office of Technology Transfer at (301) 435 4507.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.